Formulation Freedom in Clinical Development: Why Fill2Weight Matters
In early-stage pharmaceutical development, poor powder flow is rarely the root issue, it’s simply a symptom. The real challenge for formulation...
Dr. Dave Seaward : 15 March 2022
We dive back over 100 years as we look at the history of the pharmaceutical industry to see what lessons might be learnt for ATMP production.
This blog will also look the future of ATMP paradigms, taking lessons from the past.
In early-stage pharmaceutical development, poor powder flow is rarely the root issue, it’s simply a symptom. The real challenge for formulation...
Pouches are widely used in medical device packaging to provide a sterile barrier when the device itself, or its primary container, cannot inherently...
Dose Delivery Uniformity (DDU) is one of the most persistent challenges in dry-powder inhaler development, and few have tackled it more directly...